Comparison of Oral and Intravenous Definitive Antibiotic Therapy for Beta-Hemolytic Streptococcus Species Bloodstream Infections from Soft Tissue Sources: a Propensity Score-Matched Analysis-Reference-Cited by-同舟云学术

Comparison of Oral and Intravenous Definitive Antibiotic Therapy for Beta-Hemolytic Streptococcus Species Bloodstream Infections from Soft Tissue Sources: a Propensity Score-Matched Analysis

Published:2023-06-15 Issue:6 Volume:67 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Yetmar Zachary A.¹^ORCID,Chesdachai Supavit¹^ORCID,Lahr Brian D.²,Challener Douglas W.¹,Arensman Hannan Kellie N.³,Epps Kevin⁴,Stevens Ryan W.⁵,Seville Maria Teresa⁶,Tande Aaron J.¹,Virk Abinash¹

Affiliation:

1. Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA

2. Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA

3. Department of Pharmacy, Mayo Clinic, Mankato, Minnesota, USA

4. Department of Pharmacy, Mayo Clinic, Jacksonville, Florida, USA

5. Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA

6. Divison of Infectious Diseases, Mayo Clinic, Phoenix, Arizona, USA

Abstract

Beta-hemolytic streptococci are common causes of bloodstream infection (BSI). There is emerging data regarding oral antibiotics for BSI but limited for beta-hemolytic streptococcal BSI.

Funder

HHS | NIH | National Center for Advancing Translational Sciences

Mayo Clinic

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.00120-23

Reference29 articles.

1. Risk factors for bacteremia in patients with limb cellulitis

2. Age- and Sex-Associated Trends in Bloodstream Infection